Alkeran and Lipodox
Determining the interaction of Alkeran and Lipodox and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:Limited anecdotal data suggest an increased risk of doxorubicin-induced cardiomyopathy in patients who have previously received melphalan. The mechanism of this suspected interaction is unknown. Although conclusive proof that melphalan sensitizes the myocardium is lacking, anthracyclines should be administered cautiously to patients who have had extensive melphalan therapy.
- Bitran JD "Doxorubicin cardiotoxicity and melphalan" Ann Intern Med 95 (1981): 243-4
Generic Name: melphalan
Brand name: Alkeran, Alkeran IV, Evomela
Synonyms: Alkeran (Injection), ALKERAN
Generic Name: doxorubicin liposomal
Brand name: Doxil, Lipodox 50, Lipodox
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.